Journals / Türkiye Aile Hekimliği Dergisi / 2021 / Cilt: 25 - Sayı: 4

An Evaluation of Men’s Beliefs and Perceptions and Affecting Factors on Prostate Cancer Screenings with the Health Belief Model

Sağlık İnanç Modeli ile Erkeklerin Prostat Kanseri Taramalarına İlişkin İnanç ve Algı Düzeyleri ile Etkileyen Faktörlerin Değerlendirilmesi

Pages
137–144
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The study found that the participation of individuals in prostate cancer screenings was low, and their perception of health motivation and benefit was important in participating in screenings

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: People’s beliefs and perceptions affect their health behaviors.
📊
Key Findings & Data:Methods: The cross-sectional study included 100 male participants aged 35 and over who applied to the family medicine outpatient clinic between November 2020-January 2021.
💡
Conclusion & Impact:Conclusion: The study found that the participation of individuals in prostate cancer screenings was low, and their perception of health motivation and benefit was important in participating in screenings
🔬Design:Survey & Empirical Study
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: People’s beliefs and perceptions affect their health behaviors. Participation in screening for early diagnosis of prostate cancer is done with the individual’s decision in line with the physician’s recommendation. This study aimed to evaluate individuals’ health beliefs and perception levels about prostate cancer screening, one of the most common cancers in men. Methods: The cross-sectional study included 100 male participants aged 35 and over who applied to the family medicine outpatient clinic between November 2020-January 2021. The personal information form prepared by the researchers and the Prostate Cancer Screening Health Belief Model Scale was administered to the volunteer participants through a face-to-face survey method. While the obtained data were evaluated statistically, they were analyzed using the SPSS (Statistical Package for Social Sciences) program. Results: The mean age of the study participants was 45.28±7.34 (35-65) years. 22% of the participants had a prostate examination before, and only 4.0% participated in prostate cancer screening. According to the Health Belief Model, sensitivity (11.85±3.35), severity (13.17±3.39), and barrier perception (37.03±8.63) towards prostate cancer screenings were moderate. In contrast, health motivation (33.74±6.43) and perceived benefit (37.03±8.63) were high. Sensitivity perception, health motivation perception, and benefit perception were high in participants considering participating in prostate cancer screening in the future. According to the logistic regression analysis, the most critical variable affecting the prostate cancer screening status was the perception of health motivation. Conclusion: The study found that the participation of individuals in prostate cancer screenings was low, and their perception of health motivation and benefit was important in participating in screenings

Özet

Amaç: İnsanların inanç ve algıları sağlık davranışlarını etkiler. Prostat kanserinde erken tanı için yapılacak taramalara katılım hekimin önerisi doğrultusunda bireyin kararı ile yapılmaktadır. Bu çalışmada, erkeklerde sık görülen kanserlerden biri olan prostat kanseri taraması hakkında bireylerin sağlık inancı algı düzeylerini ve prostat kanseri taramalarına katılmayı etkileyen faktörleri değerlendirmek amaçlandı. Yöntem: Kesitsel tipte planlanan çalışmaya aile hekimliği polikliniğine Kasım 2020-Ocak 2021 tarihleri arasında başvuran 35 yaş ve üzeri 100 erkek katılımcı dâhil edildi. Gönüllü katılımcılara araştırmacılar tarafından hazırlanan kişisel bilgi formu ve Prostat Kanseri Taramaları Sağlık İnanç Modeli Ölçeği yüz yüze anket görüşmesi yöntemi ile uygulandı. Bulgular: Araştırmaya katılan erkeklerin yaş ortalaması 45,28±7,34 (35-65) yıl, %22,00’si daha önce prostat muayenesi olmuş ve yalnızca %4,00’ü prostat kanseri taramasına katılmıştır. Sağlık İnanç Modeline göre, prostat kanseri taramalarına yönelik duyarlılık (11,85±3,35), ciddiyet (13,17±3,39) ve engel algısı (37,03±8,63) orta düzeyde, sağlık motivasyonu (33,74±6,43) ve yarar algısının (37,03±8,63) yüksek olduğu bulundu. Gelecekte prostat kanseri taramasına katılmayı düşünen katılımcıların duyarlılık algısı, sağlık motivasyonu algısı ve yarar algısı yüksek bulundu. Lojistik regresyon analizine göre prostat taraması olma durumunu etkileyen değişkenin sağlık motivasyon algısı olarak belirlendi. Sonuç: Çalışmaya katılan bireylerin prostat kanseri taramalarına katılımının az olduğu, prostat kanseri taramalarına katılımda sağlık motivasyonu ve yarar algısının önemli olduğu bulundu.

🔖

Cite This Article

ONMAZ, M., DEMİRBAŞ, N. (2022). An Evaluation of Men’s Beliefs and Perceptions and Affecting Factors on Prostate Cancer Screenings with the Health Belief Model. Türkiye Aile Hekimliği Dergisi, Cilt: 25 - Sayı: 4, 137–144. https://ajindex.com/articles/626650

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10(2):63-89
  2. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424
  3. T.C. Sağlık Bakanlığı. Türkiye Kanser İstatistikleri 2016. Erişim adresi: https://hsgm.saglik.gov.tr/depo/birimler/ kanserdb/istatistik/Turkiye_Kanser_Istatistikleri_2016. pdf/ Erişim tarihi: 21/06/2021 4. Turner B, Drudge-Coates L. Prostate cancer: risk factors, diagnosis and management, Cancer Nursing Practice. 2010;9(1):29-36
  4. Pettersson A, Robinson D, Garmo H, et al. Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study, Ann Oncol. 2018;29(2):377-385
  5. European Association of Urology (EAU) Guidelines. Edn. presented at the EAU Annual Congress Amsterdam 2020. ISBN 978-94-92671-07-3. Erişim adresi: https://uroweb. org/guideline/prostate-cancer/Erişim tarihi:21.06.2021 7. Drazer MW, Huo D, Eggener SE. National prostate cancer screening rates after the 2012 US Preventive Services Task Force recommendation discouraging prostate-specific antigen-based screening. Journal of Clinical Oncology. 2015;33(3):2416-23
  6. Ilic D, Neuberger MM, Djulbegovic M, Dahm P. Screening for prostate cancer. Cochrane Database Syst Rev. 2013;31(1):CD004720. https://doi. org/10.1002/14651858.CD004720.pub3
  7. US Preventive Services Task Force, Grossman DC, Curry SJ, Owens DK, et al. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319(18):1901-1913. https://doi. org/10.1001/jama.2018.3710
  8. Çapık C. Prostat Kanseri Taramalarına Katılımda Engel Algısını Etkileyen Faktörlerin incelenmesi. Turkish Journal of Geriatrics. 2013;16(2):185-191
  9. Ekin RG, Zorlu F. Is prostate cancer to be screened according to Turkey data? Bulletin of Urooncology. 2013;12(2):71-75
  10. Weber MF, Cunich M, Smith DP, et al. Sociodemographic and health-related predictors of self-reported mammogram, faecal occult blood test and prostate specific antigen test use in a large Australian study. BMC Public Health. 2013;13(3):429
  11. Tabuchi T, Nakayama T, Fukushima W, et al. Determinants of participation in prostate cancer screening: A simple analytical framework to account for healthy user bias. Cancer Science. 2015;106(2):108-114. https://doi. org/10.1111/cas.12561 14. Champion VL. Instrument development for health belief model co